Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people with memory or thinking difficulties:
- You have been experiencing memory or thinking problems (either noticed by yourself or by others) for at least 6 months
- Your condition has been assessed following current official French health authority (HAS) guidelines
- You have had a spinal fluid (cerebrospinal fluid) test done at the study center and agree to allow leftover spinal fluid to be stored for research
- You are willing and able to sign a consent form agreeing to take part
- You are covered by French social security (or an equivalent scheme)
For the Alzheimer's group specifically:
- You have been diagnosed with Alzheimer's disease based on specific 2024 guidelines, confirmed by certain markers found in your spinal fluid
For the non-Alzheimer's group specifically:
- You have been diagnosed with mild or significant memory/thinking difficulties (not caused by Alzheimer's disease), confirmed by the absence of certain Alzheimer's markers in your spinal fluid
For healthy volunteers:
- You are an adult
- You have no history of neurological or psychiatric conditions
- You have no concerns about your memory or thinking ability
- You scored 27 out of 30 or higher on a standard memory test (MMSE)
- You scored 0 on a standard assessment of daily functioning related to memory (CDR-SOB)
- You are covered by French social security (or an equivalent scheme)
Who may not be able to join:
- People who are considered vulnerable (confirm with trial site for the specific definition used)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Aurélie MOUTON, MD,PhD, Centre Hospitalier Universitaire de Nice
Phone: 33492034778
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Mitochondrial oxygen consumption of peripheral blood cells; Mitochondrial oxygen consumption of peripheral blood cells
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.